Uneingeschränkter Zugang

Pneumonitis with amivantamab in squamous cell lung cancer with EGFR exon 20 insertion mutation: a case report

Margarida Melo Cruz

Margarida Melo Cruz

Serviço de Pneumologia, ULS Trás-os-Montes e Alto DouroVila Real, Portugal
Suche nach diesem Autor auf
Sciendo|Google Scholar
Cruz, Margarida Melo
, 
Ana Filipa Silva

Ana Filipa Silva

Serviço de Pneumologia, ULS Trás-os-Montes e Alto DouroVila Real, Portugal
Suche nach diesem Autor auf
Sciendo|Google Scholar
Silva, Ana Filipa
, 
Sara Raimundo

Sara Raimundo

Serviço de Pneumologia, ULS Trás-os-Montes e Alto DouroVila Real, Portugal
Suche nach diesem Autor auf
Sciendo|Google Scholar
Raimundo, Sara
 und 
Teresa Gomes

Teresa Gomes

Serviço de Pneumologia, ULS Trás-os-Montes e Alto DouroVila Real, Portugal
Suche nach diesem Autor auf
Sciendo|Google Scholar
Gomes, Teresa
  
04. Dez. 2024
Pneumonitis with amivantamab in squamous cell lung cancer with EGFR exon 20 insertion mutation: a case report's Cover Image
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zitieren
COVER HERUNTERLADEN
Artikel-Kategorie: Research Article
Online veröffentlicht: 04. Dez. 2024
Seitenbereich: 39 - 42
Eingereicht: 16. Apr. 2024
Akzeptiert: 03. Juli 2024
DOI: https://doi.org/10.2478/fco-2023-0039
Schlüsselwörter
© 2024 Margarida Melo Cruz et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1:

CT scan at diagnosis showing a right upper lobe lesion with right upper and medium lobes collapse.
CT scan at diagnosis showing a right upper lobe lesion with right upper and medium lobes collapse.

Figure 2:

CT scan after treatment with amivantamab showing scattered ground glass opacities in the left lung.
CT scan after treatment with amivantamab showing scattered ground glass opacities in the left lung.

Figure 3:

CT scan after corticosteroid treatment showing resolution of the previous opacities.
CT scan after corticosteroid treatment showing resolution of the previous opacities.

Figure 4:

CT scan after reintroduction of amivantamab, without evidence of toxicity and stable disease.
CT scan after reintroduction of amivantamab, without evidence of toxicity and stable disease.
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
2 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Allgemeinmedizin, Innere Medizin, Hämatologie, Onkologie
Zeitschrift RSS Feed